Interpreting gelatinase activity in tumor tissue and serum as a prognostic marker of naturally developing canine tumors

Journal of Veterinary Medical Science

Volumn 67, Issue 8, 2005, Pages 769-775

  Miya, Kanako ^a   Misumi, Kazuhiro ^a   Miyoshi, Noriaki ^a   Arai, Ko ^a   Fujiki, Makoto ^a   Kubota, Chikara ^a   Sakamoto, Hiroshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Gelatinase; MMP; Prognosis; Tumor; Zymography

Indexed keywords

GELATINASE; TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; COMPARATIVE STUDY; DOG; DOG DISEASE; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROGNOSIS;

ANIMALS; DOG DISEASES; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GELATINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 25644440000     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.67.769     Document Type: Article

References (22)

1. Chambers, A. F. and Matrisian, L. M. 1997. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89: 1260-1270.
2. Coughlan, A. R., Robertson, D. H., Bennett, D., May, C., Beynon, R. J. and Carter, S. D. 1998. Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis. Vet. Rec. 143: 219-223.
3. Fang, K. C., Raymond, W. W., Lazarus, S. C. and Caughey, G. H. 1996. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97: 1589-1596.
4. Hahn-Dantona, E., Ramos-DeSimone, N., Sipley, J., Nagase, H., French, D. L. and Quigley, J. P. 1999. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases. Ann. New York Acad. Sci. 878: 372-387.
5. Heussen, C. and Dowdle, E. B. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102: 196-202.
6. Hirayama, K., Yokota, H., Onai, R., Kobayashi, T., Kumata, T., Kihara, K., Okamoto, M., Sako, T., Nakade, T., Izumisawa, Y. and Taniyama, H. 2002. Detection of matrix metalloproteinases in canine mammary tumors: analysis by immunohistochemistry and zymography. J. Comp. Pathol. 127: 249-256.
7. Keck, T., Balcom, J. H. IV, Fernandez-del, Castillo, C., Antoniu, B. A. and Warshaw, A. L. 2002. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 122: 188-201.
8. La Rocca, G., Pucci-Minafra. I., Marrazzo, A., Taormina, P. and Minafra, S. 2004. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br. J. Cancer 90: 1414-1421.
9. Laack, E., Kohler, A., Kugler, C., Dierlamm, T., Knuffmann, C., Vohwinkel, G., Niestroy, A., Dahlmann, N., Peters, A., Berger, J., Fiedler, W. and Hossfeld, D. K. 2002. Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer. Ann. Oncol. 13: 1550-1557.
10. Lana, S. E., Ogilvie, G. K., Hansen, R. A., Powers, B. E., Dernell, W. S. and Withrow, S. J. 2000. Identification of matrix metalloproteinases in canine neoplastic tissue. Am. J. Vet. Res. 61: 111-114.
11. Leibman, N. F., Lana, S. E., Hansen, R. A., Powers, B. E., Fettman, M. J., Withrow, S. J. and Ogilvie, G. K. 2000. Identification of matrix metalloproteinases in canine cutaneous mast cell tumors. J. Vet. Int. Med. 14: 583-586.
12. Loukopoulos, P., Mungall, B. A., Straw, R. C., Thornton, J. R. and Robinson, W. F. 2003. Matrix metalloproteinase-2 and -9 involvement in canine tumors. Vet. Pathol. 40: 382-394.
13. Molica, S., Vitelli, G., Levato, D., Giannarelli, D., Vacca, A., Cuneo, A., Cavazzini, F., Squillace, R., Mirabelli, R. and Digiesi, G. 2003. Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia. Eur. J. Haematol. 70: 373-378.
14. Nagase, H. and Woessner, J. F. Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274: 21491-21494.
15. Papparella, S., Restucci, B., Paciello, O. and Maiolino, P. 2002. Expression of matrix metalloprotease-2 (MMP-2) and the activator membrane type 1 (MT1-MMP) in canine mammary carcinomas. J. Comp. Pathol. 126: 271-276.
16. Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D. L. and Quigley, J. P. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 274: 13066-13076.
17. Rao, V. H., Lees, G. E., Kashtan, C. E., Nemori, R., Singh, R. K., Meehan, D. T., Rodgers, K., Berridge, B. R., Bhattacharya, G. and Cosgrove, D. 2003. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int. 63: 1736-1748.
18. Volk. S. W., Kapatkin, A. S., Haskins, M. E., Wallon, R. M. and D'Angelo, M. 2003. Gelatinase activity in synovial fluid and synovium obtained from healthy and osteoarthritic joints of dogs. Am. J. Vet. Res. 64: 1225-1233.
19. Ylisirnio, S., Hoyhtya, M. and Turpeenniemi-Hujanen, T. 2000. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer- TIMP-1 as a prognostic marker. Anticancer Res. 20: 1311-1316.
20. Yokota, H., Kumata, T., Taketaba, S., Kobayashi, T., Moue, H., Taniyama, H., Hirayama, K., Kagawa, Y., Itoh, N., Fujita, O., Nakade, T. and Yuasa, A. 2001. High expression of 92 kDa type IV collagenase (matrix metalloproteinase-9) in canine mammary adenocarcinoma. Biochim. Biophys. Acta. 1568: 7-12.
21. Yoshida, D., Watanabe, K., Noha, M., Takahashi, H. and Teramoto, A. 2002. Suppression of matrix metalloproteinase activity by SI-27: detection by a new activity assay with S-2444, a specific chromogenic peptide. J. Neurooncol. 58: 1-11.
22. Zhang, X., Yamashita, M., Uetsuki, H. and Kakehi, Y. 2002. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases. Int. J. Urol. 9: 509-514.